Streamlining ChartLogic Specialty Drug Prior Auth

Klivira integrates directly with ChartLogic to automate specialty drug prior authorization, transforming a complex, manual process into an efficient, digital workflow.

For specialty ambulatory practices utilizing ChartLogic, managing prior authorizations for high-cost biologics, infused agents, and oral targeted therapies presents significant operational challenges. The intricate interplay of medical vs. pharmacy benefits, evolving payer policies, and extensive documentation requirements often leads to delays, denials, and staff burden. Klivira addresses these complexities by embedding automation directly into your ChartLogic specialty drug prior auth workflows.

The Unique Demands of Specialty Drug PA in ChartLogic Environments

Specialty practices, the core focus of ChartLogic, frequently prescribe medications requiring prior authorization that span both medical and pharmacy benefits. Without automation, staff must manually determine the correct benefit channel, navigate disparate payer portals or ePA systems like CoverMyMeds or Surescripts, and compile extensive clinical documentation. This manual burden, compounded by payer-specific step-therapy rules and site-of-care policies, directly impacts patient access to critical therapies and revenue cycle efficiency.

Seamless Integration with ChartLogic's API for Enhanced PA Workflows

Klivira connects with ChartLogic through its robust ChartLogic API, establishing a secure, bidirectional data flow. This integration allows Klivira to automatically extract essential patient data—such as demographics, diagnoses, medication orders, and prior-line therapy history—directly from ChartLogic's patient records. By leveraging this real-time data, Klivira eliminates manual data entry, ensuring PA submissions are accurate and complete from the outset, without requiring staff to leave their established ChartLogic workflows.

Automated Specialty Drug Prior Auth Workflow Powered by ChartLogic Data

  • **Automated Benefit Determination:** Klivira's policy engine analyzes ChartLogic's patient and prescription data to instantly identify whether a specialty drug falls under the medical or pharmacy benefit, routing the PA request to the correct channel automatically.
  • **Multi-Channel Submission:** Pharmacy-benefit specialty drugs are routed via ePA partners like CoverMyMeds or Surescripts using the NCPDP SCRIPT standard. Medical-benefit submissions leverage X12 278, Da Vinci PAS where available, or direct payer portal connectivity.
  • **Intelligent Documentation Assembly:** Klivira extracts relevant clinical notes, diagnosis codes, and medication history from ChartLogic to automatically populate step-therapy requirements and supporting documentation, reducing manual chart review.
  • **Site-of-Care Optimization:** For medical-benefit specialty drugs, Klivira integrates payer site-of-care policies, flagging potential mismatches before submission and helping ChartLogic users align with payer requirements.
  • **Coordinated Specialty Pharmacy Handoff:** Post-approval, Klivira streamlines the handoff to payer-preferred specialty pharmacies (e.g., Accredo, CVS Specialty, Optum Specialty), accelerating fulfillment and patient access to medication.

Addressing Common Failure Modes for ChartLogic Specialty Practices

The integration between Klivira and ChartLogic directly addresses critical points of failure in specialty drug prior authorization. Automated benefit-side determination prevents misclassification, a common cause of delays. By leveraging FHIR MedicationRequest data from ChartLogic, Klivira ensures step-therapy documentation gaps are closed. Site-of-care policy mismatches are identified proactively, and coordinated post-approval workflows mitigate specialty pharmacy fulfillment delays, ensuring patients receive their medications faster.

Adherence to Industry Interoperability Standards

Klivira's platform is built on industry-recognized standards to ensure robust and secure data exchange. For pharmacy-benefit PAs, we utilize the NCPDP SCRIPT standard, which is widely adopted for electronic prior authorization. For medical-benefit specialty drugs, Klivira leverages FHIR MedicationRequest resources for clinical data exchange and supports submissions via X12 278 and Da Vinci PAS, aligning with evolving interoperability mandates and ensuring compliance considerations are met.

Frequently asked questions

How does Klivira handle the distinction between medical and pharmacy benefits for specialty drugs within ChartLogic?

Klivira's intelligent policy engine automatically determines whether a prescribed specialty drug falls under the medical or pharmacy benefit based on payer, patient, and drug context. This determination is made using data pulled from ChartLogic, ensuring the PA request is routed to the correct channel (e.g., NCPDP SCRIPT for pharmacy, X12 278 or Da Vinci PAS for medical) without manual intervention.

What ChartLogic data does Klivira access for specialty drug prior authorizations?

Klivira accesses critical data points via the ChartLogic API, including patient demographics, active diagnoses, past medical history, current and prior medication orders, and relevant clinical notes. This comprehensive data set enables Klivira to assemble accurate and complete PA submissions, fulfilling payer requirements for medical necessity and step therapy.

Can Klivira help with site-of-care requirements for specialty infusions ordered in ChartLogic?

Yes, Klivira's platform incorporates payer-specific site-of-care policies for medical-benefit specialty drugs. When a prescription for an infused therapy is initiated in ChartLogic, Klivira can flag if the proposed site of care does not align with payer policy, allowing your team to address it before submission and avoid potential denials related to site-of-care violations.

Does Klivira integrate with specialty pharmacies after a PA is approved for ChartLogic patients?

For pharmacy-benefit specialty drugs, Klivira coordinates the post-approval workflow with specialty pharmacies. While Klivira does not manage the physical fulfillment, it streamlines the electronic handoff of approved prescriptions to the payer's designated specialty pharmacy partners (e.g., Accredo, CVS Specialty, Optum Specialty), helping to reduce delays in medication delivery.

Is Klivira's integration with ChartLogic compliant with data security standards?

Yes, Klivira adheres to robust data security and privacy standards, including HIPAA, when integrating with EMRs like ChartLogic. All data exchange via the ChartLogic API is secured, ensuring the protection of ePHI throughout the prior authorization process. We recommend discussing specific compliance considerations with your organization's compliance team.

Related coverage

Other chartlogic prior auth coverage

Ready to automate prior auth for this integration?

See how Klivira automates prior authorizations for your team.

Request a demo